SK Chemicals, GSK awaiting commercial sales of shingles vaccine
Sept 19, 2017
SK Chemicals Co., a South Korean pharmaceutical and chemical goods manufacturer, and multinational drug firm GlaxoSmithKline Plc. are awaiting final approval of their respective herpes zoster vaccines, market watchers said Tuesday.Approval is forecast to shake up the market in a big way, setting up a showdown with the US pharmaceutical giant Merck & Co's Zostavax, they said.Zostavax is the only vaccine currently approved for use to treat shingles, which typically shows up as a painful rash that